Search for Clinical Trial Results

Sponsored By

Mediastinal Neoplasms - 10 Studies Found

Status Study
Terminated Study Name: Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Condition: Mediastinal Neoplasms
Date: 2006-04-17
Interventions:
  • Drug: Intravenous Topotecan To
Completed Study Name: Echocardiographic Evaluation of the Change on Pulmonary Blood Flow and Cardiac Function Induced by Capnothorax During One Lung Ventilation
Condition: Mediastinal Tumors
Date: 2014-08-06
Interventions: Procedure: capnothorax After patient positioning, the capnothorax will be created by insufflation of car
Recruiting Study Name: The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
Condition:
  • Thymectomy
  • Myasthenia Gravis

Date: 2014-11-26
Interventions:
  • Procedure: "3-Hole" subxiphorid and subcostal approach

Completed Study Name: Controlled Trial Comparing the Performance of 22 Gauge Versus 25 Gauge EUS-FNA Needles (FNA-22G-25G)
Condition:
  • Mediastinal Tumours and Lymph Nodes
  • Celiac, Perigastric and Per
    Date: 2009-11-18
Completed Study Name: Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling
Condition:
  • Lung Cancer,
  • Mediastinal Tumors,
  • Procedure: virtual bronchoscopy guided transbronchial needle aspiration

Completed Study Name: Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults
Condition:
  • Burkitt's Lymphoma
  • Burkitt's Leukemia
  • Drug: Adriamycin
  • Drug: Cyclophosphamide
Recruiting Study Name: Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
Condition: Lung Cancer
Date: 2014-11-19
Interventions: Genetic: Genetic test Next-generation sequencing (AmpliSeq) & fusion analysis
Active, not recruiting Study Name: Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Condition:
  • Germ Cell Neoplasms
  • Testicular Neoplasms
  • Non Seminomatous
    Date: 2015-07-08
    Interventions: Drug: Pembrolizumab 200mg IV every 3 weeks until progressive disease, unacceptable toxicity, or after 52
Completed Study Name: Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
Condition:
  • Mediastinal Cancer
  • Metastatic Cancer
  • Testicular Germ Cell
    Date: 1999-11-01
    Interventions:
    • Biological: bleomycin sulfate
    • Biological:

Completed Study Name: Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
Condition:
  • Thymoma
  • Thymic Carcinoma

Date: 2007-12-25
Interventions: Drug: Belinostat (PDX101) 1000 mg/m^2/day as a 30 minute intravenous (IV) infusion daily for 5 days ever